Extended Data Table 3 Stage 2 (Pfizer) adjusted pseudovirus neutralization day 29 and day 91 GMR ANCOVA modeling

From: Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial